Clinical Trial Update: Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating T cells targeting B-cell maturation antigen (BCMA) in previously treated multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• T cells targeting B-cell maturation antigen (BCMA) (BCMA-targeted T cells)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Myeloma, Plasma-Cell, Myeloma-Multiple | Phase 1 | Status: COMPLETED | Results posted: 2019-10-08